Z-0523-2013 Class II Terminated

Recalled by Becton Dickinson & Co. — Sparks, MD

FDA device recall Z-0523-2013 was initiated by Becton Dickinson & Co. on Oct 22, 2012 and is designated Class II. Reason for recall: In vitro diagnostic test kit was not manufactured according to specifications and may cause false negatives or misidentification of Hemophilus species present in patient specimens. The recall status is terminated (terminated Jan 24, 2013). Affected quantity: 650 vials.

Recall Details

Product Type
Devices
Report Date
Dec 19, 2012
Initiation Date
Oct 22, 2012
Termination Date
Jan 24, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
650 vials

Product Description

BD BBL Taxo XV Factor Strips, Catalog number 231104, in shelf pack vials, fifty strips/vial labeled in part ***Becton, Dickinson and Company, 7 Loveton Circle, Sparks, MD 21152 USA 800-638-8663, www.bd.com/ds***

Reason for Recall

In vitro diagnostic test kit was not manufactured according to specifications and may cause false negatives or misidentification of Hemophilus species present in patient specimens.

Distribution Pattern

Worldwide Distribution - USA (nationwide) to international customers in Belgium, India, Japan, South Korea, Thailand and Mexico

Code Information

Lot number 2089253

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0523-2013
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.